Stay updated on Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page
- Check7 days agoChange DetectedThe page revision label changed from v3.6.0 to v3.6.2. This indicates a newer version of the page/document has been published.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now shows a recruitment status indicating the study is not enrolling. It also adds navigation/help items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and adjusts the Intervention/Treatment heading formatting along with a Revision: v3.6.0 note.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page footer now displays the new revision label Revision: v3.5.5, replacing Revision: v3.5.4, indicating a minor page version update.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision marker was updated from v3.5.3 to v3.5.4. This indicates a newer version of the page's documentation/template rather than a modification to trial details or results.SummaryDifference0.1%

- Check71 days agoChange DetectedThe footer revision label has been updated from v3.5.2 to v3.5.3, indicating a site/version release without changing the study details presented on the page.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.